Introducing the Atropos Evidence™ Agent–seamlessly integrating RWE into the clinical workflow.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button®
          • Alexandria®
          • Forge®
          • Atropos Evidence™ Agent
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Atropos Health Co-Founder Nigam Shah Speaks with Endpoints News

Atropos Health Co-Founder Nigam Shah Speaks with Endpoints News

by Julia Rudo | Jan 16, 2026 | News and Media

Co-founder Nigam Shah speaks with Endpoints health tech correspondent, Shelby Livingston, about general AI models like ChatGPT. He contends that while those models have commoditized the ability to search public medical journals and internet sources, they lack the...
Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old

Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old

by Julia Rudo | Jan 2, 2026 | Publications

An poster titled, “Increase in Mortality and Allograft Rejection Post-Liver Transplant in a Cohort Between 50-90 Years Old,” was presented at the American College of Gastroenterology’s (ACG) 2025 Annual Scientific Meeting & Postgraduate Course by authors...
Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study

Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study

by Julia Rudo | Dec 19, 2025 | Publications

An abstract titled, “Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study,” was published in Cephalalgia by authors Keiko Ihara, C William Pike, Gavin Hui, Saurabh Gombar, Michael...
Disparities in Atrial Fibrillation Clinical Outcomes: Race, Ethnicity, and Sex Differences in Risk of Incident Heart Failure, Stroke, and Mortality

Disparities in Atrial Fibrillation Clinical Outcomes: Race, Ethnicity, and Sex Differences in Risk of Incident Heart Failure, Stroke, and Mortality

by Julia Rudo | Dec 18, 2025 | Publications

An abstract titled, “Disparities in Atrial Fibrillation Clinical Outcomes: Race, Ethnicity, and Sex Differences in Risk of Incident Heart Failure, Stroke, and Mortality,” was published in the American Heart Association’s Circulation by authors Xichong Liu, MD, Elena...
Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

by Julia Rudo | Dec 11, 2025 | Publications

A poster titled, “Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data,” was presented at the American Society of Hematology (ASH) 67th Annual Meeting by authors...
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button®

Alexandria®

Forge®

Atropos Evidence™ Agent

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}